BRIAN COSTELLO: Open Payments
NPI 1154306454 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 23 payments from 8 companies in 2025. Trend: 2023 $664 · 2024 $798 · 2025 $542
Food & beverage: $462Education: $80
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $137 |
| Janssen Biotech, Inc. | 3 | $135 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| GENZYME CORPORATION | 3 | $54 |
| ABBVIE INC. | 2 | $34 |
| Incyte Corporation | 1 | $25 |
| Organon LLC | 1 | $11 |
Products named: OTEZLA, TREMFYA, DUPIXENT, Rhapsido, SKYRIZI, OPZELURA, COSENTYX, VTAMA.
Industry payments across NM — which companies pay providers there.
